Skip to main content
. 2017;18(5):1417–1421. doi: 10.22034/APJCP.2017.18.5.1417

Table 3.

Evaluation with Cox Regression Analysis of the Factors Affecting the Hazard Ratio of The Patients

Group 95% CI
n β p HR Min Max
Age
  <64 (Ref) 240 0.45 0.003 1
  ≥65 112 1.568 1.163 2.112
Type
  Adeno cell (Ref) 99 1
  Nos 76 0.517 0.008 1.677 1.147 2.452
  Squamous cell 106 -0.142 0.457 0.868 0.596 1.262
  Small cell 71 0.818 <0.001 2.265 1.549 3.313
Stage
  ≤3+limited (Ref) 190 0.813 <0.001 1
  4+common 162 2.254 1.709 2.972
NLR
  <3 (Ref) 160 0.303 0.031 1
  ≥3 192 1.354 1.028 1.783
ECOG
  0 (Ref) 258
  1 88 0.107 0.528 1.112 0.799 1.549
  2 6 -0.001 0.999 0.999 0.363 2.749
Hb 386 -0.119 0.008 0.898 0.813 0.97
L 386 -0.055 <0.001 0.947 0.919 0.976

Hb, Haemoglobin; L, Lymphocyte; NLR, Neutrophil to lymphocyte ratio; Ecog, Eastern Cooperative Oncology Group

HHS Vulnerability Disclosure